Regulatory Focus™ > News Articles > FDA Fights Cancer Drug Shortages

FDA Fights Cancer Drug Shortages

Posted 22 February 2012 | By

The US Food and Drug Administration (FDA) is taking steps to increase the supply of two important cancer drugs: methotrexate and doxil.

CNN's The Chart blog reported that Doxil will be replaced by Lipodox, a drug that is currently manufactured overseas and has not been approved by FDA. It has been evaluated to ensure that it does not pose any risks to patients.

FDA is boosting the supply of methotrexate with the approval of a new manufacturer and the release of addition supplies from a pharmaceutical delivery company.

The Chart reported FDA claims it has prevented 114 drug shortages since President Obama's executive order directing such action.

Read more:
CNN: FDA Continues to Fight Drug Shortages in US


Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe